Back
Probe Gold Vs. Nektar Therapeutics Industry Stock Comparison
Buy
59
PROBF
Probe Gold
Last Price:
$1.68
Seasonality Move:
15.08%
Buy
51
NKTR
Nektar Therapeutics
Last Price:
$23.83
Seasonality Move:
2.04%
Buy
59
Probe Gold (PROBF)
is a Buy
Is Probe Gold a Buy, Sell or Hold?
-
The current Probe Gold [PROBF] share price is $1.68. The Score for PROBF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
PROBF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $23.80. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PROBF Stock Price Chart
What is Probe Gold's stock price today?
-
The Probe Gold share price today is $1.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $23.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
PROBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 51.12 | Buy |
Chaikin Money Flow: | 38690 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.61 - 1.79) | Sell |
Bollinger Bands (100): | (1.32 - 1.7) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.37 | Buy |
Relative Strength Index (14 RSI): | 61.65 | Buy |
Chaikin Money Flow: | -131709 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.78 - 26.76) | Buy |
Bollinger Bands (100): | (7.5 - 18.34) | Buy |
PROBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Buy |
20-day SMA: | 1.67 | Buy |
50-day SMA: | 1.67 | Buy |
200-day SMA: | 1.37 | Buy |
8-day EMA: | 1.06 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.25 | Buy |
200-day EMA: | 0.07 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.08 | Sell |
20-day SMA: | 21.11 | Buy |
50-day SMA: | 14.55 | Buy |
200-day SMA: | 14.61 | Buy |
8-day EMA: | 18.83 | Buy |
20-day EMA: | 10.89 | Buy |
50-day EMA: | 5.14 | Buy |
200-day EMA: | 1.4 | Buy |
Probe Gold Earnings Growth & PROBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
Probe Gold Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |